Xiang Li is a Principal Scientist II at Roche, focusing on Molecular Point-of-Care assay development and technology innovation. Prior to this, Xiang Li was a Scientist at Sherlock Biosciences, working on developing accurate, fast, and affordable molecular testing platforms. Xiang Li holds a PhD from The University of Texas at Austin and has completed postdoctoral research at Harvard University and Harvard Medical School after obtaining a BS degree from Nanjing University.
2023 - present
2021
Senior Principal Scientist II at WuXi Chemistry (WuXi STA & WuXi TIDES)
Associate Principal Scientist III at Recursion Pharmaceuticals
Principal Scientist II at Mestag Therapeutics
Associate Director/principal Scientist Ii-protein Sciences at EpiBiologics
Principal Scientist II Analytical Research And Development at Owlstone Medical
Access the worlds's biggest network of public org charts
Learn more